Keyword: Presage Biosciences

Presage has snagged another major cancer player as a partner: Bristol-Myers Squibb, which will use Presage’s microdosing technology in phase 0 trials.

Celgene will use Presage’s microdosing technology conduct phase 0 trials for cancer drugs.

Presage has an intratumoral microdosing platform designed to quickly evaluate how experimental solid tumor therapies perform in humans.